Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are having minimally invasive surgery (laparoscopic or robotic) aimed at curing stomach cancer (gastric adenocarcinoma)
- People who are having surgery either as their first treatment or after receiving chemotherapy before surgery
- People who are having either a full removal of the stomach (total gastrectomy) or a partial removal of the stomach (subtotal gastrectomy)
- People who are having an extensive removal of nearby lymph nodes during their surgery (known as D2 lymphadenectomy)
Who may not be able to join:
- People under 18 years of age
- People whose cancer is located at the junction where the oesophagus meets the stomach (classified as Siewert type I, II, or III)
- People whose cancer has spread to other parts of the body (metastatic disease)
- People who are having fewer lymph nodes removed than the D2 standard
- People who are having open surgery (rather than laparoscopic or robotic)
- People whose minimally invasive surgery had to be converted to open surgery during the procedure
- People whose surgery is intended to manage symptoms rather than cure the cancer (palliative gastrectomy)
- People where cancer cells are found at or near the surgical margins after the operation (R1 or R2 resection)
- People who are having additional organs removed at the same time, except for the gallbladder
- People who are having any stomach surgery other than a full or partial stomach removal
- Cases where more than one reviewer considers a particular lymph node station impossible to assess (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Giorgio Dalmonte, MD, PhD, Azienda Ospedaliero-Universitaria di Parma
Phone: 00390521906343
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
PhotoNode Score interobserver agreement
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.